H-1 RECEPTOR ANTAGONIST TREATMENT OF CHRONIC RHINITIS

被引:47
作者
SIMONS, FER
SIMONS, KJ
机构
[1] UNIV MANITOBA,FAC MED,DEPT PEDIAT & CHILD HLTH,ALLERGY & CLIN IMMUNOL SECT,WINNIPEG R3T 2N2,MANITOBA,CANADA
[2] UNIV MANITOBA,FAC PHARM,WINNIPEG R3T 2N2,MANITOBA,CANADA
关键词
D O I
10.1016/0091-6749(88)90164-9
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:975 / 980
页数:6
相关论文
共 50 条
[1]   EVALUATION OF THE CNS PROPERTIES OF SCH-29851, A POTENTIAL NON-SEDATING ANTIHISTAMINE [J].
BARNETT, A ;
IORIO, LC ;
KREUTNER, W ;
TOZZI, S ;
AHN, HS ;
GULBENKIAN, A .
AGENTS AND ACTIONS, 1984, 14 (5-6) :590-597
[2]   PHARMACOLOGICAL EVALUATION OF LORATADINE (SCH 29851), CHLORPHENIRAMINE AND PLACEBO [J].
BATENHORST, RL ;
BATENHORST, AS ;
GRAVES, DA ;
FOSTER, TS ;
KUNG, M ;
GURAL, RP ;
AMKRAUT, HJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (02) :247-250
[3]   A COMPARATIVE-STUDY OF BECLOMETHASONE DIPROPIONATE AQUEOUS NASAL SPRAY WITH TERFENADINE TABLETS IN SEASONAL ALLERGIC RHINITIS [J].
BESWICK, KBJ ;
KENYON, GS ;
CHERRY, JR .
CURRENT MEDICAL RESEARCH AND OPINION, 1985, 9 (08) :560-567
[4]  
BONIVER R, 1986, CURR THER RES CLIN E, V39, P244
[5]  
BRANDON ML, 1980, ANN ALLERGY, V44, P71
[6]   EFFECT OF H2-BLOCKADE IN THE CHALLENGED ALLERGIC NOSE [J].
BROOKS, CD ;
BUTLER, D ;
METZLER, C .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1982, 70 (05) :373-376
[7]   LORATADINE (SCH29851) 40 MG ONCE DAILY VERSUS TERFENADINE 60 MG TWICE DAILY IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS [J].
BRUTTMANN, G ;
PEDRALI, P .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1987, 15 (02) :63-70
[8]   STIMULATORY EFFECT OF CHRONIC DRUG ADMINISTRATION ON DRUG-METABOLIZING ENZYMES IN LIVER MICROSOMES [J].
BURNS, JJ ;
CONNEY, AH ;
KOSTER, R .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1963, 104 (03) :881-&
[9]  
CALLIER J, 1981, CURR THER RES CLIN E, V29, P24
[10]   EVALUATION OF COMBINED H-1-RECEPTOR AND H-2-RECEPTOR BLOCKING-AGENTS IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS [J].
CARPENTER, GB ;
BUNKERSOLER, AL ;
NELSON, HS .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1983, 71 (04) :412-417